MDCXW — MEDICUS PHARMA LTD
MDCXW (MEDICUS PHARMA LTD) is tracked on HoldingsHub across five years of quarterly 13F filings. 4 funds have reported positions historically, with the sum of their latest reported stakes valued at $63.65K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
MDCXW is classified in the Materials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC history | 60.60K | $39.39K | 0.00% | New |
| Anson Funds Management LP history | 42.40K | $18.92K | 0.00% | New |
| Connective Capital Management, LLC history | 6.00K | $3.90K | 0.00% | New |
| UBS Group AG history | 2.20K | $1.43K | 0.00% | Add |
Q1 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 1.47K | $820 | 0.00% | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 4 funds)
| Fund | Q2 2026 | Q1 2026 |
|---|---|---|
| ARMISTICE CAPITAL, LLC | 60.60K | — |
| Anson Funds Management LP | 42.40K | — |
| Connective Capital Management, LLC | 6.00K | — |
| UBS Group AG | 2.20K | 1.47K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details